Terence J. Hadley

Norton Healthcare — United States

Medicine · Health Sciences

27h-index4.6kcitations52works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(19), Mosquito-borne diseases and control(11), Complement system in diseases(9), Blood groups and transfusion(6), Lung Cancer Treatments and Mutations(5)

Publications52 total

Successful management of the potentially fatal hyperhaemolysis syndrome of sickle cell anaemia with a regimen including bortezomib and Hemopure
Journal of Clinical Pharmacy and Therapeutics·2019· 13 cited
First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)
Cancer Investigation·2017· 6 cited
Evidence for Receptor Heterogeneity and Two Receptors
2016· 1 cited
Invasion of Erythrocytes by Malaria Parasites: Erythrocyte Ligands and Parasite Receptors
Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy·2015· 1 cited
First-line carboplatin, pemetrexed, and panitumumab in patients with advanced nonsquamous <i>KRAS</i> wild type (WT) non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2013· 1 cited
Adjuvant Chemotherapy for Breast Cancer: How Presentation of Recurrence Risk Influences Decision-Making
Journal of Clinical Oncology·2003· 88 cited
Left atrial thrombus formation on a CardioSeal Septal Occlusion device in a patient with elevated factor VIII: resolution with medical therapy.
PubMed·2003· 3 cited
EBV type 2 infection or superinfection does not contribute to development of AIDS-related non-Hodgkin's lymphoma
Evidence-based Oncology·2000
A prognostic score for advanced Hodgkin's disease
Evidence-based Oncology·2000
Up-regulation of Duffy antigen receptor expression in children with renal disease
Kidney International·1999· 72 citedOpen Access
The quality of medical evidence in hematology-oncology
The American Journal of Medicine·1999· 51 cited
Evaluating the quality of clinical guidelines. Linking decisions to medical evidence.
PubMed·1998· 18 cited
From Malaria to Chemokine Receptor: The Emerging Physiologic Role of the Duffy Blood Group Antigen
Blood·1997· 298 citedOpen Access
Expression of chemokine receptors by subsets of neurons in the central nervous system
The Journal of Immunology·1997· 382 citedOpen Access
Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines
Molecular Immunology·1996· 46 cited
Comparison of the quality of life between HIV‐positive haemophilia patients and HIV‐negative haemophilia patients
Haemophilia·1996· 26 cited
Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B
American Journal of Hematology·1996· 24 citedOpen Access
The Duffy antigen receptor for chemokines: structural analysis and expression in the brain
Journal of Leukocyte Biology·1996· 120 cited
Phase II Trial of 5-Fluorouracil, Folinic Acid, and N,N1,N11 -Triethylenethiophosphoramide (Thiotepa) in Patients with Advanced Breast Cancer
American Journal of Clinical Oncology·1995· 1 cited
The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
The Journal of Experimental Medicine·1995· 303 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Louis H. Miller(15), Benjamin Djulbegović(10), Stephen C. Peiper(7), F. Klotz(6), Geetha Joseph(6), Richard Horuk(5), Kazimiera Waśniowska(5), D E Hudson(5), Mary H. McGinniss(4), Peter H. David(4), Janell Seeger(3), J. David Haynes(3), L H Miller(3), John Hamm(3), Thomas Woodcock(3), Martin S. Blumenreich(3), Chetan E. Chitnis(2), Alvin W. Martin(2), J. Hesselgesser(2), Zhixin Lu(2)